Simon Chakko

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care

Simon Chakko, David Woska, Humberto Martínez‐Cordero et al. · The American Journal of Medicine · 1991 · 374 citations

Heart Failure, Structural Heart Disease, Cardiovascular Disease +6

Aortic Pressure Augmentation Predicts Adverse Cardiovascular Events in Patients With Established Coronary Artery Disease

Julio A. Chirinos, Juan P. Zambrano, Simon Chakko et al. · Hypertension · 2005 · 359 citations

Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: Conflicting results may lead to inappropriate care

Simon Chakko, David Woska, Humberto Martínez‐Cordero et al. · The American Journal of Medicine · 1991 · 206 citations · Full text

Heart Failure, Structural Heart Disease, Cardiovascular Disease +6